Successful Management of a Young Athlete with Type 2 Long QT Syndrome by Genotype-specific Risk Stratification and Bridging Therapy with a Wearable Cardioverter Defibrillator.

1. Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome, from genetics to management. Circ Arrhythm Electrophysiol 5: 868-877,

2012.

2. Adler A, Novelli V, Amin AS, et al. An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome. Circulation 141: 418-428, 2020.

3. Akimoto K, Furutani M, Imamura S, et al. Novel missense mutation (G601S) of HERG in a Japanese long QT syndrome family.

Hum Mutat Suppl 1: S184-S186, 1997.

4. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the

interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics

and the Association for Molecular Pathology. Genet Med 17: 405424, 2015.

5. Chockalingam P, Crotti L, Girardengo G, et al. Not all betablockers are equal in the management of long QT syndrome types

8.

9.

10.

1 and 2: higher recurrence of events under metoprolol. J Am Coll

Cardiol 60: 2092-2099, 2012.

Schwartz PJ, Ackerman MJ, George AL, Wilde AAM. Impact of

genetics on the clinical management of channelopathies. J Am

Coll Cardiol 62: 169-180, 2013.

Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype

correlation in the long-QT syndrome: gene-specific triggers for

life-threatening arrhythmias. Circulation 103: 89-95, 2001.

Ackerman MJ, Zipes DP, Kovacs RJ, et al. Eligibility and disqualification recommendation for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies:

a scientific statement from the American Heart Association and

American College of Cardiology. Circulation 132: e326-e329,

2015.

Chung MK, Szymkiewics SJ, Shao M, et al. Aggregate national

experience with the wearable cardioverter-defibrillator: event rates,

compliance and survival. J Am Coll Cardiol 56: 194-203, 2010.

Owen HJ, Bos JM, Ackerman MJ. Wearable cardioverter defibrillators for patients with long QT syndrome. Int J Cardiol 268: 132136, 2018.

The Internal Medicine is an Open Access journal distributed under the Creative

Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To

view the details of this license, please visit (https://creativecommons.org/licenses/

by-nc-nd/4.0/).

Ⓒ 2022 The Japanese Society of Internal Medicine

Intern Med 61: 1179-1182, 2022

1182

...